Total Payments
$24,476
2024 Payments
$10,741
Companies
25
Transactions
168
Medicare Patients
5,733
Medicare Billing
$485,394
Payment Breakdown by Category
Other$16,510 (67.5%)
Food & Beverage$4,027 (16.5%)
Travel$3,939 (16.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $16,510 | 8 | 67.5% |
| Food and Beverage | $4,027 | 149 | 16.5% |
| Travel and Lodging | $3,939 | 11 | 16.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $11,173 | 51 | $0 (2024) |
| Madrigal Pharmaceuticals | $10,216 | 13 | $0 (2024) |
| Echosens North America, Inc. | $1,007 | 1 | $0 (2019) |
| ABBVIE INC. | $371.76 | 31 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $343.24 | 3 | $0 (2024) |
| Medtronic, Inc. | $235.25 | 4 | $0 (2024) |
| Braintree Laboratories, Inc. | $188.49 | 19 | $0 (2019) |
| QOL Medical, LLC | $162.09 | 12 | $0 (2024) |
| Micro-tech Endoscopy USA, Inc. | $153.85 | 2 | $0 (2021) |
| Allergan Inc. | $108.56 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $10,741 | 24 | Madrigal Pharmaceuticals ($10,216) |
| 2023 | $169.39 | 9 | Gilead Sciences, Inc. ($153.36) |
| 2022 | $215.68 | 6 | Medtronic, Inc. ($152.12) |
| 2021 | $153.85 | 2 | Micro-tech Endoscopy USA, Inc. ($153.85) |
| 2020 | $74.90 | 5 | Gilead Sciences, Inc. ($35.44) |
| 2019 | $1,682 | 36 | Echosens North America, Inc. ($1,007) |
| 2018 | $399.43 | 34 | AbbVie, Inc. ($116.44) |
| 2017 | $11,040 | 52 | Gilead Sciences Inc ($10,533) |
All Payment Transactions
168 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,525.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $144.72 | General |
| Category: LIVER DISEASE | ||||||
| 11/07/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | Cash or cash equivalent | $59.00 | General |
| Category: LIVER DISEASE | ||||||
| 11/02/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $77.00 | General |
| Category: LIVER DISEASE | ||||||
| 10/02/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,935.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $318.95 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $250.00 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | Cash or cash equivalent | $239.46 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Travel and Lodging | In-kind items and services | $226.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $186.86 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $94.62 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $80.91 | General |
| Category: LIVER DISEASE | ||||||
| 09/27/2024 | Madrigal Pharmaceuticals | REZDIFFRA (Drug) | Food and Beverage | In-kind items and services | $77.39 | General |
| Category: LIVER DISEASE | ||||||
| 09/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $75.63 | General |
| 08/22/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: VIROLOGY | ||||||
| 08/01/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological), REMICADE | Food and Beverage | In-kind items and services | $126.65 | General |
| Category: Immunology | ||||||
| 05/14/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: Immunology | ||||||
| 05/01/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/19/2024 | Medtronic, Inc. | GI GENIUS (Device) | Food and Beverage | In-kind items and services | $83.13 | General |
| Category: Gastrointestinal AI | ||||||
| 02/15/2024 | Janssen Scientific Affairs, LLC | STELARA (Biological), TREMFYA | Food and Beverage | In-kind items and services | $111.26 | General |
| Category: Immunology | ||||||
| 02/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: VIROLOGY | ||||||
| 01/29/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $45.88 | General |
| 01/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $16.99 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/08/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,285 | 1,329 | $2.1M | $111,919 |
| 2022 | 11 | 1,354 | 1,398 | $2.0M | $109,454 |
| 2021 | 14 | 1,648 | 1,680 | $2.5M | $140,538 |
| 2020 | 14 | 1,446 | 1,468 | $1.9M | $123,484 |
Total Patients
5,733
Total Services
5,875
Medicare Billing
$485,394
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 294 | 300 | $478,200 | $56,174 | 11.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 387 | 395 | $605,535 | $17,786 | 2.9% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2023 | 85 | 85 | $150,025 | $10,202 | 6.8% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 114 | 118 | $172,988 | $8,309 | 4.8% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $241,407 | $5,790 | 2.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 195 | 200 | $268,200 | $4,405 | 1.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 44 | 62 | $17,918 | $4,271 | 23.8% |
| 45390 | Removal of large bowel tissue using a flexible endoscope | Facility | 2023 | 11 | 11 | $12,342 | $2,945 | 23.9% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2023 | 64 | 64 | $100,160 | $820.11 | 0.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $4,125 | $811.99 | 19.7% |
| 91200 | Measurement of liver stiffness | Facility | 2023 | 53 | 56 | $5,880 | $404.47 | 6.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 286 | 292 | $446,977 | $53,149 | 11.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 415 | 421 | $615,099 | $21,202 | 3.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 132 | 138 | $188,856 | $9,742 | 5.2% |
| 43251 | Removal of polyps or growths of esophagus, stomach, and/or upper small bowel using an endoscope with mechanical snare | Facility | 2022 | 81 | 82 | $135,292 | $9,159 | 6.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 205 | 216 | $274,152 | $4,738 | 1.7% |
| 45388 | Destruction of polyp or growth of large bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $188,765 | $4,146 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 41 | 49 | $13,366 | $3,721 | 27.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 13 | $4,918 | $1,462 | 29.7% |
| 91200 | Measurement of liver stiffness | Facility | 2022 | 92 | 96 | $11,280 | $725.95 | 6.4% |
| 45381 | Injection beneath lining of large bowel using a flexible endoscope | Facility | 2022 | 58 | 59 | $86,693 | $715.38 | 0.8% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Facility | 2022 | 12 | 12 | $28,386 | $692.87 | 2.4% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 350 | 351 | $510,003 | $65,119 | 12.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 493 | 496 | $684,480 | $24,337 | 3.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 155 | 159 | $195,570 | $11,148 | 5.7% |
About Dr. Kai Xia, MD
Dr. Kai Xia, MD is a Internal Medicine healthcare provider based in Tyler, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548236284.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kai Xia, MD has received a total of $24,476 in payments from pharmaceutical and medical device companies, with $10,741 received in 2024. These payments were reported across 168 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($16,510).
As a Medicare-enrolled provider, Xia has provided services to 5,733 Medicare beneficiaries, totaling 5,875 services with total Medicare billing of $485,394. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Tyler, TX
- Active Since 02/23/2006
- Last Updated 10/14/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1548236284
Products in Payments
- REZDIFFRA (Drug) $10,216
- Vosevi (Drug) $5,458
- Epclusa (Drug) $4,922
- FibroScan (Device) $1,007
- STELARA (Biological) $359.90
- Creon (Drug) $192.58
- SUPREP (Drug) $160.99
- All Products (Device) $143.31
- Sucraid (Drug) $125.48
- ENDOFLIP (Device) $125.00
- LINZESS (Drug) $111.80
- GI GENIUS (Device) $83.13
- ERBEJET2 (Device) $80.27
- OCA (Drug) $79.52
- PillCam (Device) $61.31
- SUCRAID (Drug) $36.61
- Humira (Biological) $34.19
- VIBERZI (Drug) $33.29
- MAVYRET (Drug) $32.07
- Vemlidy (Drug) $30.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Tyler
Dr. Pamela Mcshane, M.d, M.D
Internal Medicine — Payments: $243,956
Internal Medicine $243,956
Thomas Buzbee, M.d, M.D
Internal Medicine — Payments: $123,613
Internal Medicine $123,613
Preetham Muskula, Md, MD
Internal Medicine — Payments: $89,345
Internal Medicine $89,345
Dr. Julie Philley, Md, MD
Internal Medicine — Payments: $68,306
Internal Medicine $68,306
Alexandre Petrakian, Md, MD
Internal Medicine — Payments: $37,685
Internal Medicine $37,685
Sheldon Freeberg, M.d, M.D
Internal Medicine — Payments: $13,553
Internal Medicine $13,553